Skip to main navigation
Skip to Content
Home
Corporate
Corporate Profile
Management
Board of Directors
Corporate Governance
News & Events
News Releases
Event Calendar
Presentations & Webcasts
Stock
Stock Quote & Chart
Historical Lookup
Analyst Coverage
Financials & Filings
SEC Filings
Annual Reports
ESG
IR Resources
Investor FAQs
Email Alerts
Contact IR
Language
English
简体中文
繁體中文
Event Details
TJD5 Phase 2 Clinical Trial Data Update Call
2022.05.27 at 8:00 AM EDT
Investor Tools
Facebook
Twitter
LinkedIn
Google+
